Coriolis Pharma Research GmbH

Coriolis Pharma is a globally operating service provider and one of the world leaders in formulation research and development of (bio)pharmaceutical drugs including proteins, peptides, monoclonal antibodies, nucleic acids, viral vectors, vaccines and more. We develop liquid and lyophilized formulations and support our clients in lyophilization process development. In our state-of-the-art facilities we also offer analytical services under R&D as well as GMP and up to BSL-2. More than 700 customers trust the expertise of Coriolis. For each individual project, our highly skilled scientists develop tailor-made study designs that align with our clients’ drug development strategy. Our formulation services support all phases of drug development from early R&D to and beyond market approval. 

We are formulating innovation

Our high-quality services are driven by the scientific passion of our experts and include preformulation, (in-use) stability and forced degradation studies, supply of preclinical material and more. Our clients also benefit from our distinguished scientific advisory board that contains some of the most renowned specialists in biopharmaceutical formulation development and particle characterization: Prof. Winter, Prof. Friess, Prof. Wagner, Prof. Kersten, Prof. Schöneich, Prof. Merkel, Prof. Uchiyama, Prof. Arosio and Prof. Svilenov. They are actively involved throughout each customer project – if desired – and contribute with independent advice to a successful outcome.

  • Ausrichtungen
    • Auftragsforschung
  • Gegründet

  • Aktualisiert am